Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors.
Wahlberg, E., Karlberg, T., Kouznetsova, E., Markova, N., Macchiarulo, A., Thorsell, A.G., Pol, E., Frostell, A., Ekblad, T., Oncu, D., Kull, B., Robertson, G.M., Pellicciari, R., Schuler, H., Weigelt, J.(2012) Nat Biotechnol 30: 283-288
- PubMed: 22343925 
- DOI: https://doi.org/10.1038/nbt.2121
- Primary Citation of Related Structures:  
3GOY, 3MHJ, 3MHK, 3P0N, 3P0P, 3P0Q, 3SE2, 3SMI, 3SMJ - PubMed Abstract: 
Inhibitors of poly-ADP-ribose polymerase (PARP) family proteins are currently in clinical trials as cancer therapeutics, yet the specificity of many of these compounds is unknown. Here we evaluated a series of 185 small-molecule inhibitors, including research reagents and compounds being tested clinically, for the ability to bind to the catalytic domains of 13 of the 17 human PARP family members including the tankyrases, TNKS1 and TNKS2 ...